Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.
Also called NCT07817251
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 210 participants
- Sponsor
- Registry
-
NCT07817251
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07817251. Randomized; quadruple masking; primary purpose treatment. Start 2026-09-16 (actual); primary completion 2027-06-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- CagriSema
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct07817251- Content hash
96070012986bdfbeb3976ea80b32d4395a592e4f31234f0828afa5d8fa8f34e5